epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove albuterol
    generic
  • remove Avapro
    irbesartan
  • remove clarithromycin
    generic
  • remove Pediapred
    prednisolone
  • remove Renflexis (infliximab-abda)
    infliximab

multicheck MultiCheck Results - 6 Interactions

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face albuterol (generic) + Avapro (irbesartan)

Monitor/Modify Tx


albuterol + irbesartan

monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

Smiley face Smiley face albuterol (generic) + clarithromycin (generic)

Monitor/Modify Tx


albuterol + clarithromycin

monitor ECG: combo may incr. risk of QT prolongation, cardiac arrhythmias (additive effects)

Smiley face Smiley face albuterol (generic) + Pediapred (prednisolone)

Monitor/Modify Tx


albuterol + prednisolone

monitor potassium, BP: combo may incr. risk of hypokalemia, HTN (additive effects)

Smiley face Smiley face Avapro (irbesartan) + Pediapred (prednisolone)

Monitor/Modify Tx


irbesartan + prednisolone

monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

Caution Advised

Smiley face Smiley face clarithromycin (generic) + Pediapred (prednisolone)

Caution Advised


clarithromycin + prednisolone

caution advised: combo may incr. prednisolone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

Smiley face Smiley face Pediapred (prednisolone) + Renflexis (infliximab-abda) (infliximab)

Caution Advised


prednisolone + infliximab

caution advised: combo may incr. risk of serious infection (additive effects)

Additional Considerations

Smiley face Smiley face infliximab in Renflexis (infliximab-abda)

caution advised with narrow therapeutic index drugs; chronic inflammatory conditions may alter metabolic enzyme formation; tx with immune modulators may reverse this effect, resulting in altered levels of concomitant drugs

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information